Very Low-Dose Decitabine is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome. (April 2017) - Li, H.; Wang, L.; Wu, Y.; Su, L.; Zhao, H.; Zhang, Y.; Wang, Z.; Huang, D.; Huang, Z.; Wu, X.; Li, X.; Ye, F.; et al.